A Retrospective Analysis of the Impact of Body Mass Index on Treatment FaiLure of UsTekinumab Within an Inflammatory Bowel Disease Population (BELT-IBD)

Authors

Chukwunonso Ezeani, Baton Rouge General Medical Center, Baton Rouge, LA
Jamie Mooney, Baton Rouge General Medical Center, Baton Rouge, LA
Prabhu Ramalingam, Baton Rouge General Medical Center, Baton Rouge, LA
Mounika Lakhmalla, Baton Rouge General Medical Center, Baton Rouge, LA
Ifeanyichukwu Onor, LSU Health Sciences Center - New OrleansFollow
Hartmann Brunt, Baton Rouge General Medical Center, Baton Rouge, LA
Casey Chapman, Baton Rouge General Medical Center, Baton Rouge, LA

Document Type

Conference Proceeding

Publication Date

10-1-2024

Publication Title

American Journal of Gastroenterology

Abstract

Annual Scientific Meeting of the American College of Gastroenterology, ACG 2024, October 25 - 30, 2024, Philadelphia, PA

First Page

S1049

Last Page

S1050

Volume

119

Issue

10S

Comments

Abstract S1458

Recommended Citation

Ezeani, Chukwunonso; Mooney, Jamie; Ramalingam, Prabhu; Lakhmalla, Mounika; Onor, Ifeanyichukwu; Brunt, Hartmann; and Chapman, Casey, "A Retrospective Analysis of the Impact of Body Mass Index on Treatment FaiLure of UsTekinumab Within an Inflammatory Bowel Disease Population (BELT-IBD)" (2024). School of Medicine Faculty Publications. 3451.
https://digitalscholar.lsuhsc.edu/som_facpubs/3451
10.14309/01.ajg.0001035204.82213.1